Suven Life Sciences Limited (NSE:SUVEN)
India · Delayed Price · Currency is INR 209.00
+1.95 (0.94%)
Oct 3, 2025, 3:30 PM IST
Suven Life Sciences Market Cap
Suven Life Sciences has a market cap or net worth of 47.53 billion as of October 3, 2025. Its market cap has increased by 44.10% in one year.
Market Cap
47.53B
Enterprise Value
46.93B
Revenue
75.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
209.00
Market Cap Chart
Since July 31, 2002, Suven Life Sciences's market cap has increased from 1.61B to 47.53B, an increase of 2,849.47%. That is a compound annual growth rate of 15.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 47.20B | 69.10% |
| Dec 31, 2024 | 27.91B | 58.69% |
| Dec 29, 2023 | 17.59B | 17.75% |
| Dec 30, 2022 | 14.94B | 31.72% |
| Dec 31, 2021 | 11.34B | -1.66% |
| Dec 31, 2020 | 11.53B | -70.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,925.79B |
| Divi's Laboratories | 1,510.38B |
| Cipla | 1,222.15B |
| Apollo Hospitals Enterprise | 1,065.30B |
| Mankind Pharma | 1,005.36B |
| Zydus Lifesciences | 997.33B |
| Fortis Healthcare | 732.16B |
| Alkem Laboratories | 648.64B |